Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,185 | 350 | 90.9% |
| Education | $722.59 | 14 | 9.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,565 | 64 | $0 (2024) |
| Janssen Biotech, Inc. | $1,277 | 43 | $0 (2024) |
| ABBVIE INC. | $549.69 | 35 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $501.07 | 14 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $445.69 | 20 | $0 (2024) |
| PFIZER INC. | $384.44 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $318.53 | 16 | $0 (2023) |
| Boston Scientific Corporation | $292.85 | 18 | $0 (2024) |
| Allergan, Inc. | $225.45 | 15 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $154.83 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,396 | 63 | Sumitomo Pharma America, Inc. ($246.05) |
| 2023 | $1,891 | 68 | Janssen Biotech, Inc. ($276.68) |
| 2022 | $195.01 | 5 | Astellas Pharma US Inc ($99.99) |
| 2021 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2020 | $432.28 | 20 | Astellas Pharma US Inc ($199.95) |
| 2019 | $1,246 | 68 | Astellas Pharma US Inc ($318.16) |
| 2018 | $1,567 | 73 | Astellas Pharma US Inc ($360.92) |
| 2017 | $1,175 | 66 | Janssen Biotech, Inc. ($297.40) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: HORMONE THERAPY | ||||||
| 10/04/2024 | Boston Scientific Corporation | Moses 550 DFL (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Moses 550 DFL_URO | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Oncology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $105.16 | General |
| Category: UROLOGY | ||||||
| 09/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Prostate cancer | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/31/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 07/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/03/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: LithoVue_URO | ||||||
| 07/03/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: rezum_URO | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/08/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: rezum_URO | ||||||
| 06/06/2024 | Rochester Medical Corporation | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Urology | ||||||
| 06/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,772 | 3,629 | $479,331 | $122,739 |
| 2022 | 25 | 1,968 | 4,438 | $593,092 | $153,552 |
| 2021 | 21 | 2,021 | 3,275 | $476,693 | $132,205 |
| 2020 | 21 | 1,870 | 3,954 | $413,178 | $115,163 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 469 | $152,425 | $40,459 | 26.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 70 | 76 | $48,108 | $13,542 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 199 | $45,969 | $12,709 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 106 | 106 | $44,944 | $12,615 | 28.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 24 | 27 | $38,400 | $9,464 | 24.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 25 | 26 | $21,606 | $6,028 | 27.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 13 | 13 | $12,480 | $3,198 | 25.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $10,625 | $3,059 | 28.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 257 | 356 | $19,580 | $2,659 | 13.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 383 | 608 | $15,200 | $2,379 | 15.7% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 1,150 | $5,980 | $2,359 | 39.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 20 | 21 | $10,625 | $2,153 | 20.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 26 | 46 | $9,200 | $2,083 | 22.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 13 | 13 | $6,669 | $1,909 | 28.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,763 | $1,692 | 29.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 15 | 15 | $7,935 | $1,511 | 19.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 113 | 154 | $5,390 | $1,205 | 22.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 28 | $4,032 | $912.52 | 22.6% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 54 | 85 | $3,400 | $705.68 | 20.8% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 55 | 86 | $3,010 | $668.22 | 22.2% |
| 87088 | Bacterial urine culture | Office | 2023 | 56 | 84 | $2,940 | $652.62 | 22.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 19 | $1,900 | $468.74 | 24.7% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 14 | 14 | $3,150 | $309.09 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 577 | $187,493 | $51,179 | 27.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 80 | 92 | $58,236 | $16,247 | 27.9% |
About Dr. John Mhoon, M.D
Dr. John Mhoon, M.D is a Urology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013077510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mhoon, M.D has received a total of $7,907 in payments from pharmaceutical and medical device companies, with $1,396 received in 2024. These payments were reported across 364 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($7,185).
As a Medicare-enrolled provider, Mhoon has provided services to 7,631 Medicare beneficiaries, totaling 15,296 services with total Medicare billing of $523,658. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salem, OR
- Active Since 12/12/2006
- Last Updated 12/07/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1013077510
Products in Payments
- XTANDI (Drug) $872.07
- Erleada (Drug) $597.88
- PROVENGE (Drug) $460.36
- ZYTIGA (Drug) $439.83
- BOTOX (Biological) $400.26
- ERLEADA (Drug) $368.14
- Myrbetriq (Drug) $356.20
- GEMTESA (Drug) $295.61
- ORGOVYX (Drug) $260.73
- ELIGARD (Drug) $258.94
- MYRBETRIQ (Drug) $229.44
- Xofigo (Drug) $174.32
- XIAFLEX (Biological) $153.62
- Nubeqa (Drug) $144.21
- LYNPARZA (Drug) $140.82
- YONSA (Drug) $135.63
- BOTOX THERAPEUTIC (Biological) $122.10
- JELMYTO (Drug) $115.59
- CAMCEVI (Drug) $113.39
- Xtandi (Drug) $107.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Bradley Warner, M.d, M.D
Urology — Payments: $10,038
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Mr. Thomas Kingston, Md, MD
Urology — Payments: $6,356